INTERNATIONAL PATENT: ZEALAND PHARMA A/S FILES APPLICATION FOR "TREATMENT WITH DAPIGLUTIDE"

GENEVA, March 17 -- ZEALAND PHARMA A/S (Sydmarken 112860 Soborg) filed a patent application (PCT/EP2025/075572) for "TREATMENT WITH DAPIGLUTIDE" on Sep 09, 2025. With publication no. WO/2026/052861, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MAARBJERG, Stine Just (c/o Zealand Pharma A/SSydmarken 112860 Soborg), ZACHARIAE, Rebecca (c/o Zealand Pharma A/SSydmarken 112860 Soborg)

Abstract: The present invention relates to use of a GLP-1R/GLP-2R dual agonist, namely dapiglutide, to reduce body fat or inhibit gain of bod...